Effectiveness of mRNA Booster Vaccination Against Mild, Moderate, and Severe COVID-19 Caused by the Omicron Variant in a Large, Population-Based, Norwegian Cohort

BACKGROUND: Understanding how booster vaccination can prevent moderate and severe illness without hospitalization is crucial to evaluate the full advantage of mRNA boosters. METHODS: We followed 85 801 participants (aged 31–81 years) in 2 large population-based cohorts during the Omicron BA.1/2 wave...

Descripción completa

Detalles Bibliográficos
Autores principales: Laake, Ida, Skodvin, Siri N, Blix, Kristine, Caspersen, Ida Henriette, Gjessing, Håkon K, Juvet, Lene K, Magnus, Per, Mjaaland, Siri, Robertson, Anna H, Starrfelt, Jostein, Trogstad, Lill, Feiring, Berit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620770/
https://www.ncbi.nlm.nih.gov/pubmed/36259543
http://dx.doi.org/10.1093/infdis/jiac419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620770/
https://www.ncbi.nlm.nih.gov/pubmed/36259543
http://dx.doi.org/10.1093/infdis/jiac419

Ejemplares similares